Clinical Trial Update: Phase I Study of Patupilone and RAD001 [Phase 1]

View source ↗

Summary

Phase I study evaluating the safety and tolerability of patupilone in combination with RAD001 (everolimus) in patients with refractory malignancy; the trial has…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• Everolimus (everolimus)
• Patupilone (epothilone B)

Snippet

Sponsor: University of Medicine and Dentistry of New Jersey | Conditions: Refractory Malignancy | Phase 1 | Status: COMPLETED